管状EZH2通过抑制SDHC介导的线粒体功能来促进急性损伤
Yujie Li1, Jiaqi Zhao1, Jianing Chen1
1Department of Nephrology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Free radical biology & medicine
|February 18, 2026
概括
增强体同源2 (EZH2) 的增强剂通过抑制线粒体复合体II驱动急性损伤 (AKI). 向EZH2可能通过恢复功能为AKI提供一种新的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 急性损伤 (AKI) 具有显著的发病率和死亡率.
- 增强肠胃同类物2 (EZH2) 参与了AKI的进展.
- 在AKI中EZH2的下游机制尚不清楚.
研究的目的:
- 为了研究EZH2在AKI病变发生中的作用.
- 在AKI中确定EZH2的下游目标.
- 探索EZH2作为AKI的治疗目标.
主要方法:
- 对人类和小鼠AKI转录数据集的分析.
- 生成一个管体特异的Ezh2淘汰赛小鼠模型.
- 使用西斯普拉丁诱导AKI和缺血-再输液损伤 (IRI).
- 集成RNA-seq和EZH2 ChIP-seq用于目标识别.
- 在实验室中使用西斯丁治疗的人类管状上皮细胞进行的研究.
主要成果:
- 在AKI脏中,EZH2是上调调节的,特别是在近端管道中.
- 在AKI模型中,管体特定的Ezh2淘汰赛改善了功能障碍和组织损伤.
- EZH2抑制了酸脱酶复合体子单元C (SDHC) 的表达,这是线粒体复合体II的组成部分.
- EZH2删除恢复了SDHC表达,并赋予了因线粒体复合体II功能而取决于的再生保护.
结论:
- EZH2通过抑制SDHC表达来促进AKI.
- 准EZH2以恢复线粒体功能是AKI的潜在治疗策略.
相关概念视频
01:29Acute Kidney Injury II: Pathophysiology
1.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
01:22Acute Kidney Injury I: Introduction
851
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
851
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
359
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
359
01:20Acute Kidney Injury V: Interprofessional Care
370
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370
01:29Acute Kidney Injury III: Clinical Manifestations
1.0K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K
01:46Electron Transport Chain: Complex I and II
19.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.1K